New Delhi, : In a timely intervention to ease pressure on critical healthcare supply chains, the Government of India has announced customs duty relief measures for the pharmaceutical and medical technology (MedTech) sectors, aiming to address ongoing supply constraints and rising input costs. The move is
The three-day India MedTech Expo 2025, held at Bharat Mandapam, Pragati Maidan, New Delhi, concluded today, reaffirming India’s vision to become a global hub for precision-driven yet affordable medical technology solutions. Organized by the Department of Pharmaceuticals (DoP), Ministry of Chemicals & Fertilizers, Government of
New Delhi, September 2, 2025 – The Association of Diagnostics Manufacturers of India (ADMI) has called upon the Ministry of Commerce & Industry to urgently rationalize the inverted duty structure (IDS) affecting diagnostics kits, reagents, and in-vitro diagnostic (IVD) equipment. ADMI emphasized that the current
New Delhi: The Association of Indian Medical Device Industry (AiMeD) cautioned that changing GST rates for medical devices could impact domestic competitiveness if not carefully managed. Most devices now have a 12% GST, while inputs are taxed at 18%, causing an inverted duty structure and
